Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Initial Management of Hypokalemia with Chills

Initial Assessment

  • Evaluate severity of hypokalemia: severe hypokalemia requiring urgent treatment is characterized by serum potassium ≤2.5 mEq/L and/or ECG abnormalities (U waves, T-wave flattening) 1
  • Obtain ECG to assess for cardiac manifestations, which may include arrhythmias, especially concerning in digitalized patients 1
  • Check for signs of infection (fever, tachycardia, hypotension) as chills may indicate an infectious process 2

Treatment Algorithm

  • Start oral potassium supplementation at 20-60 mEq/day with the goal of maintaining serum potassium in the 4.5-5.0 mEq/L range 1
  • Check magnesium levels and correct any deficiency, as hypokalemia may be resistant to treatment if hypomagnesemia is present 1
  • Identify and address the underlying cause of hypokalemia (e.g., discontinue diuretics if appropriate) 1
  • Evaluate for infectious causes of chills and treat accordingly with appropriate antimicrobials if indicated 2
  • Increase dietary potassium intake through foods rich in potassium 1
  • If chills are accompanied by hyperthermia, implement cooling measures as outlined in malignant hyperthermia protocols 2
  • For patients with cardiac arrhythmias due to hypokalemia, prioritize potassium replacement and avoid bolus administration 1
  • Monitor ECG continuously during IV potassium replacement 1

Special Considerations

  • If hypokalemia is due to diuretic use, consider temporarily discontinuing the diuretic until potassium normalizes 1
  • For persistent hypokalemia despite supplementation, consider adding potassium-sparing diuretics (triamterene, amiloride, or spironolactone) 1
  • Start with low doses of potassium-sparing diuretics and check serum potassium and creatinine after 5-7 days 1
  • Be cautious with potassium-sparing diuretics when used with ACE inhibitors or large doses of oral potassium due to risk of hyperkalemia 1

Monitoring Recommendations

  • Check serum potassium and renal function 1-2 weeks after starting treatment 1
  • For patients on potassium-sparing diuretics, recheck every 5-7 days until potassium values stabilize 1
  • Monitor for signs of hyperkalemia, especially when using potassium-sparing diuretics 1

Common Pitfalls and Caveats

  • Avoid NSAIDs in patients with heart failure and hypokalemia as they can cause potassium retention 1
  • Hypokalemia may be resistant to potassium replacement if associated hypomagnesemia is not corrected 1

REFERENCES

1

Treatment of Hypokalemia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025